Skip to main content

Processa Pharmaceuticals

  • | Biotech or pharma, therapeutic R&D

Processa Pharmaceuticals (Nasdaq: PCSA) is a clinical stage drug development company with a pipeline of compounds including next generation chemotherapy. The company is seeking partners for non-core assets including PCS499, a Phase 3 ready compound for rare nephropathies.

Address

Hanover
Maryland
United States
Visit website

Contact Exhibitor


Loading
View all Exhibitors
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors